136 related articles for article (PubMed ID: 11433339)
1. Protein-based PCR for prion diseases?
Telling G
Nat Med; 2001 Jul; 7(7):778-9. PubMed ID: 11433339
[No Abstract] [Full Text] [Related]
2. Prions and prion diseases.
Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
[No Abstract] [Full Text] [Related]
3. Human prion diseases: molecular and clinical aspects.
Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
[TBL] [Abstract][Full Text] [Related]
4. Biomedicine. A view from the top--prion diseases from 10,000 feet.
Priola SA; Chesebro B; Caughey B
Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
[No Abstract] [Full Text] [Related]
5. Neurotoxic species in prion disease: a role for PrP isoforms?
Harrison CF; Barnham KJ; Hill AF
J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
[TBL] [Abstract][Full Text] [Related]
6. Prions: proof of proteinaceous nature but problems with population polymorphisms.
Griffiths PD
Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
[No Abstract] [Full Text] [Related]
7. [Prions].
Wieland S; von Weizsäcker F; Blum HE
Dtsch Med Wochenschr; 1996 Jul; 121(30):949-52. PubMed ID: 8765704
[No Abstract] [Full Text] [Related]
8. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
9. Prion diseases. Yielding under the strain.
Weissmann C
Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890
[No Abstract] [Full Text] [Related]
10. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
11. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
12. [Intermediate conformer of prion and dynamics based drug design (DBDD)].
Kazuo K
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1110-2. PubMed ID: 15168541
[No Abstract] [Full Text] [Related]
13. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
Sakudo A; Ikuta K
Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
[TBL] [Abstract][Full Text] [Related]
14. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
15. Human prion disease and human prion protein disease.
Kitamoto T; Tateishi J
Curr Top Microbiol Immunol; 1996; 207():27-34. PubMed ID: 8575204
[No Abstract] [Full Text] [Related]
16. Prion diseases: from transmission experiments to structural biology--still searching for the cause.
Liberski PP; Brown P
Folia Neuropathol; 2004; 42 Suppl A():15-32. PubMed ID: 15449457
[No Abstract] [Full Text] [Related]
17. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
18. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
19. Shrinking prions: new folds to old questions.
Aguzzi A; Brandner S
Nat Med; 1999 May; 5(5):486-7. PubMed ID: 10229220
[No Abstract] [Full Text] [Related]
20. On safari with PrP: prion diseases of animals.
Westaway D; Carlson GA; Prusiner SB
Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
